Even though we find no evidence for correlation between ABCB1 expression and prognosis in patients with serous carcinoma, which accounts for 70% to 80% of all cases, the result is limited by small number of included studies (N = 6) therefore further validation is essential. The gene discussed is ABCB1; the disease is serous adenocarcinoma.